4 completed, 2 active not recruiting, 1 withdrawn. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow PolyActiva Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension PA5436 Ocular Implant, 115mcg - Open Angle Glaucoma (OAG), Ocular Hypertension (OH) | Phase 1 | Active not recruiting | PolyActiva Pty Ltd | 12 | 2025-06-10 | 2026-07-07 |
| Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension PA5108 Ocular Implant low dose, PA5108 Ocular Implant, high dose, Latanoprost 0.005% Ophthalmic Solution - Glaucoma, Open-Angle, Ocular Hypertension | Phase 2 | Active not recruiting | PolyActiva Pty Ltd | 75 | 2025-05-31 | 2026-07-08 |
| A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery Levofloxacin Ocular Implant, Control - Cataract | Phase 1 | Withdrawn | PolyActiva Pty Ltd | 2023-06-23 | 2024-04-12 | |
| Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension. 100ng/day PA5346 Latanoprost FA SR Ocular Implant - Open Angle Glaucoma, Ocular Hypertension | Phase 1 | Completed | PolyActiva Pty Ltd | 1 | 2022-03-04 | 2024-04-12 |
| Levofloxacin Ocular Implant for Ocular Surgery Levofloxacin Ocular Implant - Cataract | Phase 1 | Completed | PolyActiva Pty Ltd | 5 | 2021-01-04 | 2021-12-08 |
| Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma PA5108 Latanoprost FA SR Ocular Implant - Open Angle Glaucoma | Phase 1 | Completed | PolyActiva Pty Ltd | 37 | 2020-03-11 | 2025-11-20 |
| Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma PA5108 - Open-angle Glaucoma | Phase 1 | Completed | PolyActiva Pty Ltd | 8 | 2018-07-24 | 2020-09-16 |
Glaucoma, Open-Angle (5) · Ocular Hypertension (3) · Cataract (2)
Latanoprost (1) · Ophthalmic Solutions (1)
Australia (5) · United States (3) · New Zealand (2)
Joseph Gira, MD (1) · Michael Coote (1) · Michael Coote, MD (1) · Nathan Kerr (1) · Tony Wells, MD (1)